P106: Bifidobacterium longum subsp. longum microbiota-secreted bioactive peptide as a novel immunomodulatory compound in the human gastrointestinal tractECCO '18 Vienna
2018
P107: MicroRNA signatures can differentiate the inflamed colonic mucosa from non-inflamed mucosa in ulcerative colitis patientsECCO '18 Vienna
2018
P108: Differential expression in colitis-associated cancer compared with Crohn’s disease and ulcerative colitisECCO '18 Vienna
2018
P109: Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitisECCO '18 Vienna
2018
P111: Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT): A possible new target in inflammatory bowel diseasesECCO '18 Vienna
2018
P113: Effects of change in the gut microbiota on colon tumorigenesis in AOM-DSS modelECCO '18 Vienna
2018
P114: Potassium competitive acid blocker, revaprazan, prevented indomethacin-induced intestinal permeability through tightening TJsECCO '18 Vienna
2018
P115: Appendectomy and ulcerative colitis: role of innate immunity in the inflammatory response of the appendicular and colonic mucosaECCO '18 Vienna
2018
P116: A computable, causal biological network model suite for mechanistic evaluation of ulcerative colitisECCO '18 Vienna
2018
P117: Serum proteomic analysis characterises newly diagnosed Crohn’s disease and ulcerative colitis depending on the age at diagnosisECCO '18 Vienna
2018
P118: Identification of colitis-associated bacteria in intestine of inflammatory bowel disease patientsECCO '18 Vienna
2018
P119: The immunohistochemical assessment of CD30+ lymphocytes in the intestinal mucosa facilitates diagnosis of paediatric ulcerative colitisECCO '18 Vienna
2018
P121: Characterising and managing issues with food-related quality of life in inflammatory bowel disease: a qualitative study of patients and healthcare professionalsECCO '18 Vienna
2018
P123: The effect of necrosis inhibition on acute DSS colitis model of inflammatory bowel diseaseECCO '18 Vienna
2018